Recurrence and new tumor development after frontline intravenous chemotherapy for retinoblastoma: Risk factors and treatment results

Kaan Gündüz(Ankara University), Funda Seher Özalp Ateş(Manisa Celal Bayar University), İbadulla Mirzayev(Ankara University), Handan Dinçaslan(Pediatric Oncology Group)
European Journal of Ophthalmology
June 30, 2021
Cited by 11


Related Papers